CJC-1295 and Ipamorelin are combined because they are complementary growth hormone secretagogues: CJC-1295 is a GHRH analog and Ipamorelin is a ghrelin-mimetic. Because they act through different mechanisms, they are frequently studied together as a blend.
Why they are paired
The two peptides come from different branches of the secretagogue family. CJC-1295 mimics GHRH, one natural signal, while Ipamorelin mimics ghrelin, a different one. Because their mechanisms are complementary rather than overlapping, researchers commonly study them together.
Studied as a blend
This complementary pairing is exactly why CJC-1295 and Ipamorelin are so often offered together in a single vial. Combining two peptides that are routinely studied side by side is the whole idea behind a peptide blend. As research compounds, both are supplied for research use only.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
A research-grade blend should ship with a batch-specific certificate of analysis covering each component. To compare the two individually, see CJC-1295 vs. Ipamorelin.
Key takeaways
- CJC-1295 is a GHRH analog; Ipamorelin is a ghrelin-mimetic.
- Their mechanisms are complementary, not overlapping.
- That is why they are studied together as a blend.
- The blend is a research compound, supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
